Stefanie Forest

1.2k total citations
12 papers, 237 citations indexed

About

Stefanie Forest is a scholar working on Physiology, Infectious Diseases and Cellular and Molecular Neuroscience. According to data from OpenAlex, Stefanie Forest has authored 12 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Infectious Diseases and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Stefanie Forest's work include Alzheimer's disease research and treatments (4 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Stefanie Forest is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Stefanie Forest collaborates with scholars based in United States. Stefanie Forest's co-authors include Eldad A. Hod, Peter Davies, Cristina d’Abramo, Christopher M. Acker, Ray Zinkowski, Michael K. Parides, Jay A. Graham, Adriana I. Colovai, Juan P. Rocca and Milan Kinkhabwala and has published in prestigious journals such as Kidney International, Critical Care Medicine and Neurobiology of Aging.

In The Last Decade

Stefanie Forest

11 papers receiving 232 citations

Peers

Stefanie Forest
Mahmoud Al‐Kofahi United States
Anupama Tiwari United States
J.W. Chiles United States
Sirazum Choudhury United Kingdom
Denise O’Donnell United States
Mahmoud Al‐Kofahi United States
Stefanie Forest
Citations per year, relative to Stefanie Forest Stefanie Forest (= 1×) peers Mahmoud Al‐Kofahi

Countries citing papers authored by Stefanie Forest

Since Specialization
Citations

This map shows the geographic impact of Stefanie Forest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Forest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Forest more than expected).

Fields of papers citing papers by Stefanie Forest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Forest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Forest. The network helps show where Stefanie Forest may publish in the future.

Co-authorship network of co-authors of Stefanie Forest

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Forest. A scholar is included among the top collaborators of Stefanie Forest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Forest. Stefanie Forest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Asante, Dennis, et al.. (2023). Equity and Performance Improvement: A Novel Toolkit That Makes Using an Equity Lens the Default. The Joint Commission Journal on Quality and Patient Safety. 50(1). 75–82. 2 indexed citations
2.
Cowman, Kelsie, Inessa Gendlina, Yi Guo, et al.. (2022). Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients. Diagnostic Microbiology and Infectious Disease. 103(4). 115721–115721. 5 indexed citations
3.
Forest, Stefanie, Erika P. Orner, D. Goldstein, et al.. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Qualitative Immunoglobulin G Assays: The Value of Numeric Reporting. Archives of Pathology & Laboratory Medicine. 145(8). 929–936.
4.
Azzi, Yorg, Michael K. Parides, Omar Alani, et al.. (2020). COVID-19 infection in kidney transplant recipients at the epicenter of pandemics. Kidney International. 98(6). 1559–1567. 88 indexed citations
5.
Forest, S., Robert E. Michler, John P. Skendelas, et al.. (2020). De Novo Renal Failure and Clinical Outcomes of Patients With Critical Coronavirus Disease 2019. Critical Care Medicine. 49(2). e161–e169. 10 indexed citations
6.
Forest, Stefanie, et al.. (2017). Flow Cytometry of Body Fluid Specimens: Diagnostic Value and Clinical Utility in Patients With or Without Prior Hematologic Malignancy. American Journal of Clinical Pathology. 147(suppl_2). S178–S179. 1 indexed citations
7.
Forest, Stefanie, et al.. (2016). The Impact of an Electronic Ordering System on Blood Bank Specimen Rejection Rates. American Journal of Clinical Pathology. 147(1). 105–109. 7 indexed citations
8.
Forest, Stefanie & Eldad A. Hod. (2016). Management of the Platelet Refractory Patient. Hematology/Oncology Clinics of North America. 30(3). 665–677. 41 indexed citations
9.
d’Abramo, Cristina, Christopher M. Acker, Joel B. Schachter, et al.. (2015). Detecting tau in serum of transgenic animal models after tau immunotherapy treatment. Neurobiology of Aging. 37. 58–65. 17 indexed citations
10.
Acker, Christopher M., Stefanie Forest, Ray Zinkowski, Peter Davies, & Cristina d’Abramo. (2012). Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models. Neurobiology of Aging. 34(1). 338–350. 48 indexed citations
11.
Acker, Christopher M., Stefanie Forest, Ray Zinkowski, Peter Davies, & Cristina d’Abramo. (2012). P3‐004: Sensitive quantitative assays for tau and phospho‐tau in transgenic mouse models. Alzheimer s & Dementia. 8(4S_Part_12). 1 indexed citations
12.
Forest, Stefanie, Christopher M. Acker, Cristina d’Abramo, & Peter Davies. (2012). Methods for Measuring Tau Pathology in Transgenic Mouse Models. Journal of Alzheimer s Disease. 33(2). 463–471. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026